Future investigations should focus on determining whether activation of AHR leads to stimulation of IDO expression, and consequently promotes production of tryptophan metabolites such as kynurenine, which potentially mediate the neurological disorders and/or autoimmune diseases in dioxin-exposed people. This evidence concerns the gene IDO1 and autoimmune disease.